Study Comparing Tigecycline vs. Levofloxacin in Subjects Hospitalized With Community-Acquired Pneumonia

NCT00081575 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

434

Enrollment

INDUSTRY

Sponsor class

Conditions

Community-Acquired Infections
Bacterial Pneumonia
Cross Infection

Interventions

DRUG: Tigecycline
DRUG: Levofloxacin

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer